Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07822152) titled 'Human Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic Nephropathy' on Sept. 9.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Tongji Hospital

Condition: Diabetic Nephropathy

Intervention: Drug: UC-MSCs

Recruitment Status: Recruiting

Phase: Phase 1

Date of First Enrollment: March 25, 2026

Target Sample Size: 15

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07822152

Published by HT Digital Content Services with per...